REFERENCES
- Modlin IM, Lye KD, Kidd K. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003;97:934–959.
- Zimmerman LE, Stangl R, Riddle PJ. Primary carcinoid tumor of the orbit. A clinicopathologic study with histochemical and electron microscopic observations. Arch Ophthalmol 1983;101:1395–1398.
- Shetlar DJ, Font RL, Ordonez N, et al. A clinicopathologic study of three carcinoid tumors metastatic to the orbit. Immunohistochemical, ultrastructural, and DNA flow cytometric studies. Ophthalmology 1990;97:257–264.
- Mehta JS, Abou-Rayyah Y, Rose G. Orbital carcinoid metastasis. Ophthalmology 2006;113:466–472.
- Knox RJ, Gigantelli JW, Arthurs BP. Recurrent orbital inflammation from metastatic orbital carcinoid tumor. Ophth Plast Recon Surg 2001;17:137–139.
- Kaltsas G, Korbonits M, Heintz E, et al. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 2001;86:895–902.
- Critchley M. Octreotide scanning for carcinoid tumours. Postgrad Med J 1997;73:399–402.
- Dromain C, de Baere T., Caillet HL, et al. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol 2005;23, 70–78.
- Hanson MW, Schneider AM, Enterline DS, Feldman JM, Gockerman JP. Iodine-131-metaiodobenzylguanidine uptake in metastatic carcinoid tumor to the orbit. J Nucl Med1998;39:647–650.
- Isidori AM, Kaltsas G, Frajese V, et al. Ocular metastases secondary to carcinoid tumors: The utility of imaging with [13I] meta-iodobenzylguanidine and [111In] DTPA pentetreotide. J Clin Endocrinol Metab 2002;87:1627–1633.